UK Column News - Wednesday, 2nd November 2022 54:19 - Huge money in jabs—even before people are born

 

UK Column News - Wednesday, 2nd November 2022 54:19 - Huge money in jabs—even before people are born

54:19 MHRA Board Meeting ticket booking time is here again
55:19 Independent: Dozens of children vaccine-overdosed
56:23 Health Service Journal (HSJ) Patient Safety Congress: £199 to hear the Patient Safety Commissioner, Dr Henrietta Hughes
58:03 Citeline: the new name for Datamonitor pharmaceutical consultancy/intelligence
Cambridge Cluster: more magic than medicine

VacZine Analytics helps its clients predict the market for immune-based therapies
Graphs show exponential growth of jab industry: trebled to £60 billion

Cambridgeshire Live: Norovirus scare in Peterborough (see also Debi Evans' blog)
Express: Young children flu season warning
Forbes: First RSV vaccine on the horizon—Pfizer trial

1:04:39 EndPoints News: Pfizer declares first-ever Phase III success for RSV vaccine in infants—immunity in utero

 

Appeal to viewers: Who is VacZine Analytics' John Savopoulos (pharmaceutical intelligence)? Is he related to the other Savopoulos noted at the company? What is his background?